Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of COVID-19 vaccination strategies with a delayed second dose
Seyed M. Moghadas, Thomas N. Vilches, Kevin Zhang, et al.
PLoS Biology (2021) Vol. 19, Iss. 4, pp. e3001211-e3001211
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
John S. Tregoning, Katie E. Flight, Sophie L. Higham, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 626-636
Open Access | Times Cited: 1035
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 126
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals
Brian Grunau, David A. Goldfarb, Michael Asamoah-Boaheng, et al.
JAMA (2021) Vol. 327, Iss. 3, pp. 279-279
Open Access | Times Cited: 85
COVID-19 vaccine strategies must focus on severe disease and global equity
Peter McIntyre, Rakesh Aggarwal, Ilesh Jani, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 406-410
Open Access | Times Cited: 78
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study
Santiago Romero‐Brufau, Ayush Chopra, Alex J Ryu, et al.
BMJ (2021), pp. n1087-n1087
Open Access | Times Cited: 75
Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo
Matt D. T. Hitchings, Otávio T. Ranzani, Murilo Dorión, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 71
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
Nerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 9, pp. 1437-1453.e8
Open Access | Times Cited: 70
Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
Ivan Fan‐Ngai Hung, Gregory A. Poland
The Lancet (2021) Vol. 397, Iss. 10277, pp. 854-855
Open Access | Times Cited: 68
Optimizing COVID-19 vaccination programs during vaccine shortages
Kaihui Liu, Yijun Lou
Infectious Disease Modelling (2022) Vol. 7, Iss. 1, pp. 286-298
Open Access | Times Cited: 47
Risk assessment of COVID-19 epidemic resurgence in relation to SARS-CoV-2 variants and vaccination passes
Tyll Krueger, Krzysztof Gogolewski, Marcin Bodych, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 45
COVID-19 vaccine distribution planning using a congested queuing system—A real case from Australia
Hamed Jahani, Amir Eshaghi Chaleshtori, Seyed Mohammad Sadegh Khaksar, et al.
Transportation Research Part E Logistics and Transportation Review (2022) Vol. 163, pp. 102749-102749
Open Access | Times Cited: 45
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Bi‐objective optimization of a stochastic resilient vaccine distribution network in the context of the COVID‐19 pandemic
Mehrdad Mohammadi, Milad Dehghan, Amir Pirayesh, et al.
Omega (2022) Vol. 113, pp. 102725-102725
Open Access | Times Cited: 39
Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection
José Javier Morales‐Núñez, José Francisco Muñoz‐Valle, Carlos Meza-López, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 742-742
Open Access | Times Cited: 53
Lives saved and hospitalizations averted by COVID-19 vaccination in New York City: a modeling study
Affan Shoukat, Thomas N. Vilches, Seyed M. Moghadas, et al.
The Lancet Regional Health - Americas (2021) Vol. 5, pp. 100085-100085
Open Access | Times Cited: 50
Efficient social distancing during the COVID-19 pandemic: Integrating economic and public health considerations
Kexin Chen, Chi Seng Pun, Hoi Ying Wong
European Journal of Operational Research (2021) Vol. 304, Iss. 1, pp. 84-98
Open Access | Times Cited: 45
A model predictive control approach to optimally devise a two‐dose vaccination rollout: A case study on COVID‐19 in Italy
Francesco Parino, Lorenzo Zino, Giuseppe C. Calafiore, et al.
International Journal of Robust and Nonlinear Control (2021) Vol. 33, Iss. 9, pp. 4808-4823
Open Access | Times Cited: 40
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
Jostein Starrfelt, Anders Skyrud Danielsen, Eirik Alnes Buanes, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Vaccination strategies and transmission of COVID-19: Evidence across advanced countries
Dongwoo Kim, Young Jun Lee
Journal of Health Economics (2022) Vol. 82, pp. 102589-102589
Open Access | Times Cited: 28
Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis
Yang Liu, Carl A. B. Pearson, Frank Sandmann, et al.
The Lancet Regional Health - Europe (2022) Vol. 17, pp. 100381-100381
Open Access | Times Cited: 28
Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study
Natsuko Imai, Thomas Rawson, Edward Knock, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 3, pp. e174-e183
Open Access | Times Cited: 19
Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models
Gilberto González‐Parra, Md. Shahriar Mahmud, Claus Kadelka
Infectious Disease Modelling (2024) Vol. 9, Iss. 4, pp. 1057-1080
Open Access | Times Cited: 6
Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization
Raghu Arghal, Harvey Rubin, Shirin Saeedi Bidokhti, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316294-e0316294
Open Access
Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada
Thomas N. Vilches, Kevin Zhang, Robert Van Exan, et al.
Vaccine (2021) Vol. 39, Iss. 17, pp. 2360-2365
Open Access | Times Cited: 35
Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology
Jamie M. Caldwell, Xuan Le, Lorin McIntosh, et al.
Paediatric Respiratory Reviews (2021) Vol. 39, pp. 32-39
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top